Sublocade stays in your system far longer than most medications. After your final injection, buprenorphine can remain detectable in your blood and urine for 12 months or longer, depending on how many injections you’ve received. The drug’s unusually slow elimination is by design: it forms a solid deposit under your skin that gradually breaks down over many months.
Why Sublocade Lasts So Long
Unlike a pill that dissolves in your stomach within minutes, Sublocade is injected as a liquid under the skin of your abdomen. Once it contacts your body’s fluids, it hardens into a small solid deposit called a depot. This depot slowly biodegrades over time, steadily releasing buprenorphine into your bloodstream. Think of it like a time-release capsule, except it works over months instead of hours.
This delivery mechanism is what makes the elimination timeline so extended. Your body isn’t just processing a single dose of medication. It’s gradually absorbing buprenorphine from a physical mass that takes a long time to fully break down. Each monthly injection adds a new depot, and older ones may still be partially releasing medication when the next one arrives.
The Elimination Timeline
The terminal half-life of Sublocade ranges from 43 to 60 days. That means it takes roughly six to nine weeks for just half of the remaining buprenorphine from a single depot to clear your body. Using the standard pharmacological rule that a drug is essentially gone after about five half-lives, most people would have no trace of Sublocade left after 172 to 300 days from a single injection. That’s roughly 6 to 10 months.
But that estimate applies to someone who received only one injection. If you’ve been on Sublocade for several months, buprenorphine accumulates in your system because new depots are added before old ones fully dissolve. After 4 to 6 months of treatment, you reach what’s called steady state, where the drug builds up to a consistent level. At that point, the clearance timeline stretches considerably.
How Dose Size Affects Clearance
Sublocade comes in two doses: 300 mg (the loading dose, typically given for the first two months) and 100 mg (the maintenance dose). The size of your most recent doses directly affects how long therapeutic levels persist after stopping.
FDA modeling data shows that after discontinuation, buprenorphine plasma concentrations remain at therapeutic levels for 2 to 5 months on average. The lower end of that range corresponds to the 100 mg dose, while the higher end reflects the 300 mg dose. If your last several injections were the higher dose, expect a longer tail of active medication in your system.
Detection in Drug Tests
This is where the timeline gets particularly long. After reaching steady state (4 to 6 months of treatment), patients who stop Sublocade may have detectable levels of buprenorphine in both plasma and urine for 12 months or longer. An FDA study that followed patients 22 to 38 months after their last injection found that buprenorphine could still potentially be detected in plasma and urine across that entire window.
This matters if you’re transitioning to a different medication, entering a treatment program with specific drug testing requirements, or need to be clear of opioids for any reason. Standard urine tests for buprenorphine will likely show positive results for many months after your final shot. If you need documentation that you were prescribed Sublocade, keep your treatment records accessible.
What Happens When You Stop
One of Sublocade’s practical advantages is also what makes its elimination so gradual: there’s no abrupt drop-off when you stop treatment. After your last injection, plasma levels decrease slowly over the following months. For the first 2 to 5 months, levels typically stay in the therapeutic range, which means you continue receiving the medication’s effects even though you’re no longer getting injections. This built-in taper helps reduce the risk of withdrawal symptoms compared to suddenly stopping oral buprenorphine.
After those initial months, levels continue declining but remain detectable. The residual concentrations from previous injections decrease gradually over subsequent months. How quickly you personally clear the drug depends on several factors, though the differences between individuals are smaller than you might expect.
Factors That Influence Your Timeline
FDA pharmacokinetic analyses identified BMI and sex as factors that influence how quickly buprenorphine absorbs from the depot. BMI affects both how fast your body clears the drug and how quickly the depot releases it. Sex influences the slower phase of absorption from the depot. However, these differences are modest in practical terms. BMI, for example, was statistically measurable but explained only about 1% of the variation in treatment outcomes.
The factors that matter most are ones you already know: how many injections you received, what dose you were on, and how long you were treated. Someone who received three injections will clear the drug faster than someone who received twelve. Beyond that, the 43-to-60-day half-life range already accounts for much of the natural variation between people.
Quick Reference: Approximate Timelines
- Therapeutic blood levels after stopping: 2 to 5 months, depending on dose
- Detectable in urine and blood (after steady state): 12 months or longer
- Complete elimination (single injection): roughly 6 to 10 months
- Complete elimination (after months of treatment): potentially 12 to 38 months based on detection data
These are averages and estimates. The 12-month-plus detection window comes directly from FDA labeling, and the longer end of the range reflects findings from patients followed well beyond a year after their last injection. If you need precise information about your own clearance for medical or legal purposes, blood testing can measure your current buprenorphine levels directly.

